Solventum Co. (NYSE:SOLV) Given Average Rating of “Hold” by Analysts

Solventum Co. (NYSE:SOLV) has been given an average recommendation of “Hold” by the eleven research firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $68.29.

Several brokerages have recently weighed in on SOLV. Wolfe Research began coverage on Solventum in a research note on Thursday, September 26th. They set a “peer perform” rating for the company. Morgan Stanley increased their target price on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Mizuho began coverage on shares of Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target on the stock. Stifel Nicolaus started coverage on shares of Solventum in a report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective for the company. Finally, Piper Sandler increased their price target on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th.

Institutional Trading of Solventum

A number of hedge funds and other institutional investors have recently made changes to their positions in SOLV. Nordea Investment Management AB grew its position in Solventum by 189.5% in the fourth quarter. Nordea Investment Management AB now owns 659,887 shares of the company’s stock worth $43,902,000 after buying an additional 431,986 shares during the last quarter. Everence Capital Management Inc. acquired a new stake in Solventum during the 4th quarter worth about $305,000. Modus Advisors LLC purchased a new stake in Solventum during the fourth quarter valued at about $25,000. GAMMA Investing LLC increased its position in shares of Solventum by 35.3% in the fourth quarter. GAMMA Investing LLC now owns 3,329 shares of the company’s stock worth $220,000 after acquiring an additional 868 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its position in shares of Solventum by 3.0% in the 3rd quarter. Principal Financial Group Inc. now owns 169,615 shares of the company’s stock valued at $11,826,000 after acquiring an additional 4,896 shares in the last quarter.

Solventum Stock Performance

Shares of NYSE:SOLV opened at $68.87 on Friday. The company has a 50 day moving average of $69.42 and a two-hundred day moving average of $64.69. Solventum has a 52-week low of $47.16 and a 52-week high of $96.05. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.